EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium

Lixin Du, Huiling Lu, Yifei Xiao, Zhihua Guo, Ya Li iD

PLOS ONE · 2024

DOI: 10.1371/journal.pone.0301036 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2024. Verfasst von Lixin Du und 4 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China. Hauptthemen laut MEDLINE: Hydrogen Peroxide, PPAR alpha, Flavonols. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine, Hunan University students innovation and entrepreneurship training program, the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

This study aims to investigate the protective mechanism of dihydromyricetin PLGA nanoparticles (DMY-PLGA NPs) against myocardial ischemia-reperfusion injury (MIRI) in vitro and the improvement of oral bioavailability in vivo.

Methods

DMY-PLGA NPs was prepared and characterized by emulsifying solvent volatilization, and the oxidative stress model of rat H9c2 cardiomyocyte induced by H 2 O 2 was established. After administration, cell survival rate, lactate dehydrogenase (LDH), malondialdehyde (MDA) and superoxide dismutase (SOD) were detected, and the expressions of PGC1α and PPARα were detected by western blot (WB). At the same time, the pharmacokinetics in rats were studied to explore the improvement of bioavailability.

Results

DMY-PLGA NPs can significantly increase cell survival rate, decrease LDH and MDA content, increase SOD content and PGC1α、PPARα protein expression. Compared with DMY, the peak time of DMY-PLGA NPs was extended ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Hydrogen PeroxidePPAR alphaFlavonolsRatsAnimalsPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaOxidative StressMyocardiumMyocytes, CardiacSuperoxide DismutaseApoptosis

Substanzen

dihydromyricetinHydrogen PeroxidePPAR alphaPeroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alphaSuperoxide DismutaseFlavonols

Autor:innen und Institutionen

  • School of Pharmacy, Hunan University of Chinese Medicine, Changsha, China.
  • School of Chinese Medicine, Hunan University of Chinese Medicine, Changsha, China.

ORCID-Profile: Ya Li

Förderung

  • Key Discipline Project on Chinese Pharmacology of Hunan University of Chinese Medicine
  • Hunan University students innovation and entrepreneurship training program
  • the National Natural Science Foundation of China
  • Hunan graduate research innovation project

Zitieren

APA

Du, L., Lu, H., Xiao, Y., Guo, Z., & Li, Y. (2024). Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium. PLOS ONE. https://doi.org/10.1371/journal.pone.0301036

Vancouver

Du L, Lu H, Xiao Y, Guo Z, Li Y. Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium. PLOS ONE. 2024. doi:10.1371/journal.pone.0301036

BibTeX
@article{Du2024,
  author = {Du, Lixin and Lu, Huiling and Xiao, Yifei and Guo, Zhihua and Li, Ya},
  title = {Protective effect and pharmacokinetics of dihydromyricetin nanoparticles on oxidative damage of myocardium},
  journal = {PLOS ONE},
  year = {2024},
  doi = {10.1371/journal.pone.0301036}
}
Kostenlos starten →